Byline: Associated Press
The World Health Organization has given final approval to an injectable
female contraceptive long dogged by safety concerns.
The U.N. health agency said Tuesday that Depo Provera, officially known as DMPA, did not increase the risk of breast, cervical or ovarian cancer. It said there was evidence that the contraceptive, which is injected every three months, protected women against cancer of the uterus.
"The results are …
Комментариев нет:
Отправить комментарий